Biotech · Private company
MapKure, LLC
Track this companyFree. Adds MapKure, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- BGB-3245Phase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- BrimarafenibPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PanitumumabPhase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal CancersPHASE1 · TERMINATED · started Apr 18, 2024ClinicalTrials.gov NCT06194877 · fetched Nov 12, 2026
- Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory TumorsPHASE1 · TERMINATED · started Feb 10, 2020ClinicalTrials.gov NCT04249843 · fetched Nov 12, 2026